Research Article
Role of miRNA-495 and NRXN-1 and CNTN-1 mRNA Expression and Its Prognostic Importance in Breast Cancer Patients
Table 5
ROC curve for microRNA-495, NRXN-1, and CNTN-1 w.r.t. TNM stages (early stage and advanced stage).
| | AUC for microRNA-495 (95% CI) | Sensitivity | Specificity | Cutoff value (fold change) | p value | | 0.63 (0.50–0.75) | 65% | 62% | 0.03-fold | 0.02 |
| | AUC for NRXN-1 (95% CI) | Sensitivity | Specificity | Cutoff value (fold change) | p value | | 0.97 (0.94–1.0) | 93% | 90% | 4.5-fold | <0.0001 |
| | AUC for CNTN-1 (95% CI) | Sensitivity | Specificity | Cutoff value (fold change) | p value | | 0.95 (0.91–0.98) | 90% | 82% | 3.12-fold | <0.0001 |
|
|
